insights_auto
Why is GMED up 3,51%?
Dive Deeperchevron_right
GMED:NYSE
Globus Medical Inc
USDÂ 78,95
arrow_upward
+3,51%(+2,67) 1D
15 Okt., 15:56:33 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMED...
Open
USDÂ 77,66
High
USDÂ 79,26
Low
USDÂ 77,05
Mkt. cap
10,60Â mjd
Avg. vol.
1,54Â m
Volume
1,27Â m
P/E ratio
20,20
52-wk high
USDÂ 101,40
52-wk low
USDÂ 58,32
EPS
USDÂ 3,91
Beta
0,96
Shares outstanding
112,62Â m
No. of employees
6Â k
Open
USDÂ 77,66
High
USDÂ 79,26
Low
USDÂ 77,05
Mkt. cap
10,60Â mjd
Avg. vol.
1,54Â m
Volume
1,27Â m
P/E ratio
20,20
52-wk high
USDÂ 101,40
52-wk low
USDÂ 58,32
EPS
USDÂ 3,91
Beta
0,96
Shares outstanding
112,62Â m
No. of employees
6Â k
News stories
From web sources and news partners
Zacks
·
2 uur gelede
BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients
ad-hoc-news.de
·
3 uur gelede
RBC cuts target to USD 85.00 for Globus Medical stock
Zacks
·
4 uur gelede
Doximity Deepens U.S. News Alliance to Improve Patient Access to Care
Zacks
·
5 uur gelede
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
Profile
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders. Wikipedia
About Globus Medical Inc